 | • レポートコード：D0GIR-01266 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、関節炎治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。関節炎治療薬の種類別市場規模（生物製剤、非生物製剤）、用途別市場規模（関節リウマチ、変形性関節症、乾癬性関節炎、強直性脊椎炎、線維筋痛症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Bristol-Myers Squibb、AstraZeneca、Merck.、Baxter、Novartis、Eli Lilly、Amgen、Abbott、F. Hoffmann-La Roche、Johnson & Johnson、Pfizer、GlaxoSmithKline、Celgene ・地域別グローバル市場分析 2015年-2020年 ・関節炎治療薬の北米市場（アメリカ、カナダ、メキシコ） ・関節炎治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・関節炎治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・関節炎治療薬の南米市場（ブラジル、アルゼンチン） ・関節炎治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生物製剤、非生物製剤 ・用途別分析：関節リウマチ、変形性関節症、乾癬性関節炎、強直性脊椎炎、線維筋痛症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Arthritic Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 32190 million by 2025, from USD 28030 million in 2019.
The Arthritic Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Arthritic Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Arthritic Therapeutic market has been segmented into:
Biologics
Non-biologics
By Application, Arthritic Therapeutic has been segmented into:
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Arthritic Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Arthritic Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Arthritic Therapeutic market.
The report offers in-depth assessment of the growth and other aspects of the Arthritic Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Arthritic Therapeutic Market Share Analysis
Arthritic Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Arthritic Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Arthritic Therapeutic sales, revenue and market share for each player covered in this report.
The major players covered in Arthritic Therapeutic are:
AbbVie
Bristol-Myers Squibb
AstraZeneca
Merck.
Baxter
Novartis
Eli Lilly
Amgen
Abbott
F. Hoffmann-La Roche
Johnson & Johnson
Pfizer
GlaxoSmithKline
Celgene
Table of Contents
1 Arthritic Therapeutic Market Overview
1.1 Product Overview and Scope of Arthritic Therapeutic
1.2 Classification of Arthritic Therapeutic by Type
1.2.1 Global Arthritic Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Arthritic Therapeutic Revenue Market Share by Type in 2019
1.2.3 Biologics
1.2.4 Non-biologics
1.3 Global Arthritic Therapeutic Market by Application
1.3.1 Overview: Global Arthritic Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Others
1.4 Global Arthritic Therapeutic Market by Regions
1.4.1 Global Arthritic Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Arthritic Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Arthritic Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Arthritic Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Arthritic Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Arthritic Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Arthritic Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck.
2.4.1 Merck. Details
2.4.2 Merck. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck. SWOT Analysis
2.4.4 Merck. Product and Services
2.4.5 Merck. Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Baxter SWOT Analysis
2.5.4 Baxter Product and Services
2.5.5 Baxter Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eli Lilly SWOT Analysis
2.7.4 Eli Lilly Product and Services
2.7.5 Eli Lilly Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott SWOT Analysis
2.9.4 Abbott Product and Services
2.9.5 Abbott Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.10 F. Hoffmann-La Roche
2.10.1 F. Hoffmann-La Roche Details
2.10.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 F. Hoffmann-La Roche SWOT Analysis
2.10.4 F. Hoffmann-La Roche Product and Services
2.10.5 F. Hoffmann-La Roche Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Johnson & Johnson SWOT Analysis
2.11.4 Johnson & Johnson Product and Services
2.11.5 Johnson & Johnson Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Pfizer SWOT Analysis
2.12.4 Pfizer Product and Services
2.12.5 Pfizer Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GlaxoSmithKline SWOT Analysis
2.13.4 GlaxoSmithKline Product and Services
2.13.5 GlaxoSmithKline Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.14 Celgene
2.14.1 Celgene Details
2.14.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Celgene SWOT Analysis
2.14.4 Celgene Product and Services
2.14.5 Celgene Arthritic Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Arthritic Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Arthritic Therapeutic Players Market Share
3.2.2 Top 10 Arthritic Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Arthritic Therapeutic Revenue and Market Share by Regions
4.2 North America Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Arthritic Therapeutic Revenue by Countries
5.1 North America Arthritic Therapeutic Revenue by Countries (2015-2020)
5.2 USA Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Arthritic Therapeutic Revenue by Countries
6.1 Europe Arthritic Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Arthritic Therapeutic Revenue by Countries
7.1 Asia-Pacific Arthritic Therapeutic Revenue by Countries (2015-2020)
7.2 China Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Arthritic Therapeutic Revenue by Countries
8.1 South America Arthritic Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Arthritic Therapeutic by Countries
9.1 Middle East & Africa Arthritic Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Arthritic Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Arthritic Therapeutic Market Forecast by Type (2019-2024)
10.3 Biologics Revenue Growth Rate (2015-2025)
10.4 Non-biologics Revenue Growth Rate (2015-2025)
11 Global Arthritic Therapeutic Market Segment by Application
11.1 Global Arthritic Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Arthritic Therapeutic Market Forecast by Application (2019-2024)
11.3 Rheumatoid Arthritis Revenue Growth (2015-2020)
11.4 Osteoarthritis Revenue Growth (2015-2020)
11.5 Psoriatic Arthritis Revenue Growth (2015-2020)
11.6 Ankylosing Spondylitis Revenue Growth (2015-2020)
11.7 Fibromyalgia Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Arthritic Therapeutic Market Size Forecast (2021-2025)
12.1 Global Arthritic Therapeutic Market Size Forecast (2021-2025)
12.2 Global Arthritic Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Arthritic Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Arthritic Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Arthritic Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Arthritic Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Arthritic Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Arthritic Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Arthritic Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Arthritic Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Arthritic Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Corporate Information, Location and Competitors
Table 6. AbbVie Arthritic Therapeutic Major Business
Table 7. AbbVie Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie SWOT Analysis
Table 9. AbbVie Arthritic Therapeutic Product and Solutions
Table 10. AbbVie Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 12. Bristol-Myers Squibb Arthritic Therapeutic Major Business
Table 13. Bristol-Myers Squibb Arthritic Therapeutic Total Revenue (USD Million) (2018-2019)
Table 14. Bristol-Myers Squibb SWOT Analysis
Table 15. Bristol-Myers Squibb Arthritic Therapeutic Product and Solutions
Table 16. Bristol-Myers Squibb Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. AstraZeneca Corporate Information, Location and Competitors
Table 18. AstraZeneca Arthritic Therapeutic Major Business
Table 19. AstraZeneca Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 20. AstraZeneca SWOT Analysis
Table 21. AstraZeneca Arthritic Therapeutic Product and Solutions
Table 22. AstraZeneca Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck. Corporate Information, Location and Competitors
Table 24. Merck. Arthritic Therapeutic Major Business
Table 25. Merck. Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 26. Merck. SWOT Analysis
Table 27. Merck. Arthritic Therapeutic Product and Solutions
Table 28. Merck. Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Baxter Corporate Information, Location and Competitors
Table 30. Baxter Arthritic Therapeutic Major Business
Table 31. Baxter Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 32. Baxter SWOT Analysis
Table 33. Baxter Arthritic Therapeutic Product and Solutions
Table 34. Baxter Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Arthritic Therapeutic Major Business
Table 37. Novartis Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Arthritic Therapeutic Product and Solutions
Table 40. Novartis Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eli Lilly Corporate Information, Location and Competitors
Table 42. Eli Lilly Arthritic Therapeutic Major Business
Table 43. Eli Lilly Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 44. Eli Lilly SWOT Analysis
Table 45. Eli Lilly Arthritic Therapeutic Product and Solutions
Table 46. Eli Lilly Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Amgen Corporate Information, Location and Competitors
Table 48. Amgen Arthritic Therapeutic Major Business
Table 49. Amgen Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 50. Amgen SWOT Analysis
Table 51. Amgen Arthritic Therapeutic Product and Solutions
Table 52. Amgen Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Corporate Information, Location and Competitors
Table 54. Abbott Arthritic Therapeutic Major Business
Table 55. Abbott Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 56. Abbott SWOT Analysis
Table 57. Abbott Arthritic Therapeutic Product and Solutions
Table 58. Abbott Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 60. F. Hoffmann-La Roche Arthritic Therapeutic Major Business
Table 61. F. Hoffmann-La Roche Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 62. F. Hoffmann-La Roche SWOT Analysis
Table 63. F. Hoffmann-La Roche Arthritic Therapeutic Product and Solutions
Table 64. F. Hoffmann-La Roche Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Johnson & Johnson Corporate Information, Location and Competitors
Table 66. Johnson & Johnson Arthritic Therapeutic Major Business
Table 67. Johnson & Johnson Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 68. Johnson & Johnson SWOT Analysis
Table 69. Johnson & Johnson Arthritic Therapeutic Product and Solutions
Table 70. Johnson & Johnson Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Pfizer Corporate Information, Location and Competitors
Table 72. Pfizer Arthritic Therapeutic Major Business
Table 73. Pfizer Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 74. Pfizer SWOT Analysis
Table 75. Pfizer Arthritic Therapeutic Product and Solutions
Table 76. Pfizer Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. GlaxoSmithKline Corporate Information, Location and Competitors
Table 78. GlaxoSmithKline Arthritic Therapeutic Major Business
Table 79. GlaxoSmithKline Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 80. GlaxoSmithKline SWOT Analysis
Table 81. GlaxoSmithKline Arthritic Therapeutic Product and Solutions
Table 82. GlaxoSmithKline Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Celgene Corporate Information, Location and Competitors
Table 84. Celgene Arthritic Therapeutic Major Business
Table 85. Celgene Arthritic Therapeutic Total Revenue (USD Million) (2017-2018)
Table 86. Celgene SWOT Analysis
Table 87. Celgene Arthritic Therapeutic Product and Solutions
Table 88. Celgene Arthritic Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Arthritic Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 90. Global Arthritic Therapeutic Revenue Share by Players (2015-2020)
Table 91. Global Arthritic Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Arthritic Therapeutic Revenue Market Share by Regions (2015-2020)
Table 93. North America Arthritic Therapeutic Revenue by Countries (2015-2020)
Table 94. North America Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Table 95. Europe Arthritic Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Arthritic Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Arthritic Therapeutic Revenue by Countries (2015-2020)
Table 98. South America Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Arthritic Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Table 101. Global Arthritic Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 102. Global Arthritic Therapeutic Revenue Share by Type (2015-2020)
Table 103. Global Arthritic Therapeutic Revenue Forecast by Type (2021-2025)
Table 104. Global Arthritic Therapeutic Revenue by Application (2015-2020)
Table 105. Global Arthritic Therapeutic Revenue Share by Application (2015-2020)
Table 106. Global Arthritic Therapeutic Revenue Forecast by Application (2021-2025)
Table 107. Global Arthritic Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Arthritic Therapeutic Picture
Figure 2. Global Arthritic Therapeutic Revenue Market Share by Type in 2019
Figure 3. Biologics Picture
Figure 4. Non-biologics Picture
Figure 5. Arthritic Therapeutic Revenue Market Share by Application in 2019
Figure 6. Rheumatoid Arthritis Picture
Figure 7. Osteoarthritis Picture
Figure 8. Psoriatic Arthritis Picture
Figure 9. Ankylosing Spondylitis Picture
Figure 10. Fibromyalgia Picture
Figure 11. Others Picture
Figure 12. Global Arthritic Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Arthritic Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Arthritic Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Arthritic Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Arthritic Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Arthritic Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Arthritic Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Arthritic Therapeutic Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Arthritic Therapeutic Revenue Market Share in 2019
Figure 21. Global Top 10 Players Arthritic Therapeutic Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Arthritic Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Arthritic Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 25. Global Arthritic Therapeutic Revenue Market Share by Regions in 2018
Figure 26. North America Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Europe Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 29. South America Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. North America Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 32. North America Arthritic Therapeutic Revenue Market Share by Countries in 2019
Figure 33. USA Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 34. Canada Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. Europe Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Arthritic Therapeutic Revenue Market Share by Countries in 2019
Figure 38. Germany Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. UK Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. France Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 41. Russia Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 42. Italy Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Arthritic Therapeutic Revenue Market Share by Countries in 2019
Figure 45. China Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Japan Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. Korea Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 48. India Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. South America Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 51. South America Arthritic Therapeutic Revenue Market Share by Countries in 2019
Figure 52. Brazil Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Arthritic Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Arthritic Therapeutic Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. UAE Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Arthritic Therapeutic Revenue and Growth Rate (2015-2020)
Figure 60. Global Arthritic Therapeutic Revenue Share by Type (2015-2020)
Figure 61. Global Arthritic Therapeutic Revenue Share by Type in 2019
Figure 62. Global Arthritic Therapeutic Market Share Forecast by Type (2021-2025)
Figure 63. Global Biologics Revenue Growth Rate (2015-2020)
Figure 64. Global Non-biologics Revenue Growth Rate (2015-2020)
Figure 65. Global Arthritic Therapeutic Revenue Share by Application (2015-2020)
Figure 66. Global Arthritic Therapeutic Revenue Share by Application in 2019
Figure 67. Global Arthritic Therapeutic Market Share Forecast by Application (2021-2025)
Figure 68. Global Rheumatoid Arthritis Revenue Growth Rate (2015-2020)
Figure 69. Global Osteoarthritis Revenue Growth Rate (2015-2020)
Figure 70. Global Psoriatic Arthritis Revenue Growth Rate (2015-2020)
Figure 71. Global Ankylosing Spondylitis Revenue Growth Rate (2015-2020)
Figure 72. Global Fibromyalgia Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Arthritic Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Arthritic Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Arthritic Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Arthritic Therapeutic Revenue Market Forecast (2021-2025)
Figure 78. Europe Arthritic Therapeutic Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Arthritic Therapeutic Revenue Market Forecast (2021-2025)
Figure 80. South America Arthritic Therapeutic Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Arthritic Therapeutic Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
脊髄性筋萎縮症（SMA）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Spinal Muscular Atrophy (SMA) Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…- 外分泌膵不全治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Exocrine Pancreatic Insufficiency Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- TDP治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The TDP Therapeutic Apparatus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 抗菌治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Antibacterial Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 124550 million by 2025, from USD 110400 million in 2019. The Antibacter…
- 医療用弱視治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medical Amblyopia Therapeutic Apparatus market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medic…